Previous studies have established the link between PDGFRB overexpression and a poor prognosis in patients with renal cell carcinoma [37], oral squamous cell carcinoma [38], ovarian cancer [39], and colorectal cancer [40]. The gene discussed is PDGFRB; the disease is hereditary clear cell renal cell carcinoma.